tiprankstipranks
Caribou Biosciences (CRBU)
NASDAQ:CRBU
US Market

Caribou Biosciences (CRBU) Income Statement

927 Followers

Caribou Biosciences Income Statement

Last quarter (Q4 2025), Caribou Biosciences's total revenue was $3.94M, an increase of 89.74% from the same quarter last year. In Q4, Caribou Biosciences's net income was $-26.49M. See Caribou Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 11.16M$ 9.99M$ 34.48M$ 13.85M$ 9.60M
Gross Profit
$ 7.51M$ 6.07M$ 30.95M$ 10.21M$ 8.61M
Operating Expenses
$ 143.71M$ 172.68M$ 147.01M$ 116.61M$ 75.59M
Depreciation and Amortization
$ 3.65M$ 3.93M$ 3.52M$ 3.64M$ 984.00K
EBITDA
$ -132.55M$ -162.69M$ -112.53M$ -95.71M$ -65.61M
Operating Income
$ -136.19M$ -166.62M$ -116.06M$ -106.40M$ -66.98M
Other Income/Expenses
$ -12.48M$ 17.50M$ 14.18M$ 7.05M$ 377.00K
Pretax Income
$ -148.68M$ -149.11M$ -101.88M$ -99.35M$ -66.60M
Net Income
$ -148.13M$ -149.10M$ -102.07M$ -99.42M$ -66.92M
Per Share Metrics
Basic EPS
$ -1.59$ -1.65$ -1.38$ -1.64$ -1.11
Diluted EPS
$ -1.59$ -1.65$ -1.38$ -1.64$ -1.11
Weighted Average Shares Outstanding
93.39M 90.32M 73.81M 60.80M 60.26M
Weighted Average Shares Outstanding (Diluted)
93.39M 90.32M 73.81M 60.80M 60.26M
Currency in USD

Caribou Biosciences Earnings and Revenue History